Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone808-326-1353
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$30.20 million
Profitability
Miscellaneous
Employees118
Next Earnings Date11/11/2019 (Estimated)
OptionableNot Optionable
Cyanotech (NASDAQ:CYAN) Frequently Asked Questions
What is Cyanotech's stock symbol?
Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."
How were Cyanotech's earnings last quarter?
Cyanotech Corp (NASDAQ:CYAN) posted its earnings results on Tuesday, August, 13th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The biotechnology company earned $8.07 million during the quarter. Cyanotech had a negative net margin of 7.88% and a negative return on equity of 15.79%. View Cyanotech's Earnings History.
When is Cyanotech's next earnings date?
Has Cyanotech been receiving favorable news coverage?
Media headlines about CYAN stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cyanotech earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Cyanotech.
Are investors shorting Cyanotech?
Cyanotech saw a decrease in short interest in the month of September. As of September 15th, there was short interest totalling 1,800 shares, a decrease of 10.0% from the August 15th total of 2,000 shares. Based on an average daily trading volume, of 2,700 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.0% of the company's shares are short sold. View Cyanotech's Current Options Chain.
Who are some of Cyanotech's key competitors?
What other stocks do shareholders of Cyanotech own?
Who are Cyanotech's key executives?
Cyanotech's management team includes the folowing people:
- Mr. Mawae R. Morton, Chief Exec. Officer (Age 52)
- Dr. Gerald R. Cysewski Ph.D., Co-Founder, Pres & Vice Chairman (Age 70)
- Mr. Brian Brett Orlopp, VP of Fin. & CFO and Sec.
- Mr. Glenn D. Jensen, VP of Manufacturing & Infrastructure (Age 61)
How do I buy shares of Cyanotech?
Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cyanotech's stock price today?
One share of CYAN stock can currently be purchased for approximately $2.44.
How big of a company is Cyanotech?
What is Cyanotech's official website?
How can I contact Cyanotech?
Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]
MarketBeat Community Rating for Cyanotech (NASDAQ CYAN)
MarketBeat's community ratings are surveys of what our community members think about Cyanotech and other stocks. Vote "Outperform" if you believe CYAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
